New report predicts medical membranes to reach $2.3 billion by 2012
WELLESLEY, MA, July 31, 2007 -- In a recently released BCC Research report, Medical Membrane Devices: Markets And Technologies (MST043C), the medical membrane device market, including dialyzers, blood oxygenators, IV filters and blood/apheresis filters, is valued at nearly $1.8 billion in 2007 and is increasing at a compound annual growth rate (CAGR) of 5.3%. It will reach $2,3 billion by 2012.
The combined worth of market-driven devices (dialyzers and blood oxygenators and IV filters) is about $623 million, rising at a compound annual growth rate of 3.6%. Growth in the hemodialyzer market is driven by an increasing patient population, the phaseout of reusable dialyzers and the discovery that nonmembrane home dialysis may be applicable to a broader target audience.
Surgical procedures that traditionally required heart lung bypass are continuing to increase in the U.S., but sales of membrane blood oxygenators are diminishing. Advances and alternatives in cardiac surgery could make these devices a thing of the past.
Technology driven products, such as blood/apheresis microfilters and diagnostic devices, have a combined value of $1.1 billion, with a 6.2% CAGR. Sales of these products for the most part, are spurred by improvements in design and materials, and by new applications.
Sales of diagnostic devices continue to skyrocket. Competition abounds in this lucrative industry. Advanced methods for in vitro testing are capturing a portion of the membrane diagnostic market.
For more information on this and other BCC Research reports, see: http://www.bccresearch.com